A new once-daily "Quad" pill might be added to the arsenal of effective HIV treatments in the near future, according to a new study. Paul Sax, HMS professor of medicine at Brigham and Women’s Hospital, led the research.
Read full article
Stay informed via email on the latest news, research and media from Harvard Medical School. SIGN UP